Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CHEK2 |
Variant | Q209* |
Impact List | nonsense |
Protein Effect | loss of function |
Gene Variant Descriptions | CHEK2 Q209* results in a premature truncation of the Chek2 protein at amino acid 209 of 543 (UniProt.org). Q209* results in decreased Chek2 protein expression and phosphorylation in cultured cells and leads to a loss of growth inhibition in response to DNA damage (PMID: 33606978). |
Associated Drug Resistance | |
Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 Q209* |
Transcript | NM_007194.4 |
gDNA | chr22:g.28719453G>A |
cDNA | c.625C>T |
Protein | p.Q209* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_145862.2 | chr22:g.28719453G>A | c.625C>T | p.Q209* | RefSeq | GRCh38/hg38 |
NM_007194.4 | chr22:g.28719453G>A | c.625C>T | p.Q209* | RefSeq | GRCh38/hg38 |
NM_007194.3 | chr22:g.28719453G>A | c.625C>T | p.Q209* | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28719453G>A | c.625C>T | p.Q209* | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|